GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seelos Therapeutics Inc (NAS:SEEL) » Definitions » Cyclically Adjusted PB Ratio

Seelos Therapeutics (Seelos Therapeutics) Cyclically Adjusted PB Ratio : 0.02 (As of Jun. 14, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Seelos Therapeutics Cyclically Adjusted PB Ratio?

As of today (2024-06-14), Seelos Therapeutics's current share price is $0.9424. Seelos Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $43.15. Seelos Therapeutics's Cyclically Adjusted PB Ratio for today is 0.02.

The historical rank and industry rank for Seelos Therapeutics's Cyclically Adjusted PB Ratio or its related term are showing as below:

SEEL' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.09   Max: 5.09
Current: 0.02

During the past years, Seelos Therapeutics's highest Cyclically Adjusted PB Ratio was 5.09. The lowest was 0.01. And the median was 0.09.

SEEL's Cyclically Adjusted PB Ratio is ranked better than
96.67% of 661 companies
in the Biotechnology industry
Industry Median: 1.7 vs SEEL: 0.02

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Seelos Therapeutics's adjusted book value per share data for the three months ended in Mar. 2024 was $-17.359. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $43.15 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Seelos Therapeutics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Seelos Therapeutics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seelos Therapeutics Cyclically Adjusted PB Ratio Chart

Seelos Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.04 0.05 0.06 0.02

Seelos Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.14 0.03 0.02 0.11

Competitive Comparison of Seelos Therapeutics's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Seelos Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Seelos Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Seelos Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Seelos Therapeutics's Cyclically Adjusted PB Ratio falls into.



Seelos Therapeutics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Seelos Therapeutics's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.9424/43.15
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Seelos Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Seelos Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-17.359/131.7762*131.7762
=-17.359

Current CPI (Mar. 2024) = 131.7762.

Seelos Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201406 22,352.830 100.560 29,291.822
201409 21,421.429 100.428 28,108.099
201412 3,095.161 99.070 4,116.986
201503 2,385.714 99.621 3,155.760
201506 -4,642.857 100.684 -6,076.623
201509 -11,301.429 100.392 -14,834.517
201512 -14,205.714 99.792 -18,758.693
201603 -7,956.977 100.470 -10,436.310
201606 -10,977.907 101.688 -14,226.118
201609 -7,043.925 101.861 -9,112.631
201612 -7,024.299 101.863 -9,087.089
201703 779.630 102.862 998.780
201706 3,692.135 103.349 4,707.690
201709 3,023.445 104.136 3,825.955
201712 2,071.564 104.011 2,624.555
201803 1,888.987 105.290 2,364.182
201806 1,620.859 106.317 2,009.002
201809 1,051.918 106.507 1,301.493
201812 656.122 105.998 815.688
201903 36.060 107.251 44.306
201906 55.707 108.070 67.927
201909 92.154 108.329 112.100
201912 -0.062 108.420 -0.075
202003 36.897 108.902 44.647
202006 20.036 108.767 24.274
202009 30.150 109.815 36.180
202012 11.319 109.897 13.573
202103 75.909 111.754 89.509
202106 194.068 114.631 223.094
202109 170.962 115.734 194.659
202112 130.404 117.630 146.087
202203 103.730 121.301 112.688
202206 59.275 125.017 62.480
202209 17.645 125.227 18.568
202212 -23.763 125.222 -25.007
202303 -40.701 127.348 -42.116
202306 -91.178 128.729 -93.337
202309 -45.761 129.860 -46.436
202312 -27.370 129.419 -27.868
202403 -17.359 131.776 -17.359

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Seelos Therapeutics  (NAS:SEEL) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Seelos Therapeutics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Seelos Therapeutics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Seelos Therapeutics (Seelos Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
300 Park Avenue, 2nd Floor, New York, NY, USA, 10022
Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders.
Executives
Raj Mehra director, officer: See Remarks C/O SEELOS THERAPEUTICS, INC., 300 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10022
Michael Joseph Golembiewski officer: Chief Financial Officer 7 TURTLE CT, FLEMINGTON NJ 08822
Daniel J. O'connor director C/O SEELOS THERAPEUTICS, INC., 300 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10022
Margaret Dalesandro director ONCOSEC MEDICAL INCORPORATED, 24 NORTH MAIN STREET, PENNINGTON NJ 08534
Judith Dunn director C/O SEELOS THERAPEUTICS, INC., 300 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10022
Brian Lian director C/O SEELOS THERAPEUTICS, INC., 300 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10022
Robin L Smith director C/O PHASE III MEDICAL, INC., 330 SOUTH SERVICE ROAD, SUITE 120, MELVILLE NY 11747
Neil Morton officer: SVP, Chief Business Officer C/O APRICUS BIOSCIENCES, INC., 11975 EL CAMINO REAL, SUITE 300, SAN DIEGO CA 92130
Richard W Pascoe director, officer: CEO & Secretary C/O SEELOS THERAPEUTICS, INC., 300 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10022
Armistice Capital, Llc 10 percent owner 510 MADISON AVENUE, 7TH FLOOR, NEW YORK NY 10022
Armistice Capital Master Fund Ltd. 10 percent owner C/O ARMISTICE CAPITAL, LLC, 510 MADISON AVENUE, 7TH FLOOR, NEW YORK NY 10022
Steven Boyd 10 percent owner 510 MADISON AVENUE, 7TH FLOOR, NEW YORK NY 10022
Alexander J Denner 10 percent owner C/O SARISSA CAPITAL MANAGEMENT LP, 660 STEAMBOAT ROAD, 3RD FLOOR, GREENWICH CT 06830
Sarissa Capital Management Lp 10 percent owner 660 STEAMBOAT ROAD, GREENWICH CT 06830
Sarissa Capital Domestic Fund Lp 10 percent owner 660 STEAMBOAT ROAD, 3RD FLOOR, GREENWICH CT 06830

Seelos Therapeutics (Seelos Therapeutics) Headlines

From GuruFocus